ATE132909T1 - Vefahren zur diagnose von störungen der blutgerinnung - Google Patents
Vefahren zur diagnose von störungen der blutgerinnungInfo
- Publication number
- ATE132909T1 ATE132909T1 AT92913443T AT92913443T ATE132909T1 AT E132909 T1 ATE132909 T1 AT E132909T1 AT 92913443 T AT92913443 T AT 92913443T AT 92913443 T AT92913443 T AT 92913443T AT E132909 T1 ATE132909 T1 AT E132909T1
- Authority
- AT
- Austria
- Prior art keywords
- conversion
- sample
- rate
- blood clotting
- clotting disorders
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96433—Serine endopeptidases (3.4.21)
- G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
- G01N2333/96461—Protein C (3.4.21.69)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9103332A SE470274B (sv) | 1991-11-13 | 1991-11-13 | Användning av en in vitro-metod för diagnos av blodkoagulationssjukdomar |
US81130391A | 1991-12-20 | 1991-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE132909T1 true ATE132909T1 (de) | 1996-01-15 |
Family
ID=26661244
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT92913443T ATE132909T1 (de) | 1991-11-13 | 1992-05-13 | Vefahren zur diagnose von störungen der blutgerinnung |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0608235B2 (de) |
JP (1) | JP2562000B2 (de) |
AT (1) | ATE132909T1 (de) |
CA (1) | CA2119761C (de) |
DE (2) | DE69207607T3 (de) |
DK (1) | DK0608235T4 (de) |
ES (1) | ES2081618T5 (de) |
GR (1) | GR3018646T3 (de) |
HK (1) | HK31697A (de) |
WO (1) | WO1993010261A1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4229933A1 (de) * | 1992-09-08 | 1994-03-10 | Max Planck Gesellschaft | Verfahren zur Bestimmung von Thrombose verursachenden Lupus-anticoagulant-Antikörpern |
US7169572B1 (en) * | 1993-01-29 | 2007-01-30 | T.A.C. Thrombosis And Coagulation Ab | Assays for determining anticoagulant cofactor activity |
US5472852A (en) * | 1993-09-15 | 1995-12-05 | Oklahoma Medical Research Foundation | Assay for detection of selective Protein C inhibition by patients |
CA2137041C (en) * | 1993-12-03 | 2003-06-10 | Katalin Varadi | Assay for determining sensitivity to activated protein c |
JP3163105B2 (ja) | 1994-02-14 | 2001-05-08 | リヤクス・ユニフアーシテイト・レイデン | 血栓症及び/又は活性化プロテインcに対する弱い抗凝血応答に関連した遺伝性欠陥の存在をスクリーニングする方法 |
DE4418635C2 (de) * | 1994-05-27 | 1997-07-24 | Immuno Ag | Pharmazeutische Zusammensetzung zur Vorbeugung und Behandlung von Blutgerinnungsstörungen |
AUPM731394A0 (en) * | 1994-08-05 | 1994-09-01 | Life Therapeutics Limited | Improved activated protein c resistance test |
ES2154703T5 (es) † | 1994-11-10 | 2008-02-01 | Dade Behring Marburg Gmbh | Procedimiento para la deteccion especifica de un factor de coagulacion v activado con una estabilidad elevada frente a proteina c activada. |
US5705395A (en) * | 1994-11-14 | 1998-01-06 | The Scripps Research Institute | Method for diagnosis of thrombotic disorders |
US6867045B1 (en) | 1994-11-14 | 2005-03-15 | The Scripps Research Institute | Method for diagnosis of thrombotic disorders |
ATE200710T1 (de) † | 1994-12-23 | 2001-05-15 | Diagnostic Reagents Ltd | Verfahren zur diagnose von blutgerinnungsstörungen |
US5874256A (en) * | 1995-06-06 | 1999-02-23 | Rijks Universiteit Leiden | Method for diagnosing an increased risk for thrombosis or a genetic defect causing thrombosis and kit for use with the same |
US5780255A (en) * | 1995-06-09 | 1998-07-14 | Instrumentation Laboratory, S.P.A. | Protein C pathway screening test |
AT403289B (de) * | 1996-01-30 | 1997-12-29 | Immuno Ag | Verfahren zur herstellung eines standardisierten plasmapools für diagnostische zwecke |
US6379975B1 (en) | 1996-11-27 | 2002-04-30 | T.A.C. Thrombosis And Coagulation Aktiebolag | Methods and reagents for determining protein S |
FR2764389B1 (fr) * | 1997-06-06 | 1999-08-06 | Stago Diagnostica | Utilisation de venin de crotalus viridis helleri, procede et necessaire pour la determination de la reactivite de la proteine c activee |
DE19724239A1 (de) * | 1997-06-09 | 1998-12-10 | Max Planck Gesellschaft | Dysprothrombinämie |
US6743596B1 (en) * | 2000-10-27 | 2004-06-01 | Biomerieux, Inc. | Method of determining global coagulability hemostatic potential |
US6855509B2 (en) | 2000-12-19 | 2005-02-15 | Instrumentation Laboratory Company | Protein S functional assay and kit therefor |
US7696309B2 (en) * | 2006-10-23 | 2010-04-13 | The Brigham And Women's Hospital, Inc. | Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
CN103747795A (zh) | 2011-06-07 | 2014-04-23 | 美索布拉斯特国际有限公司 | 使用基质细胞衍生因子-1的蛋白酶抵抗突变体修复组织损伤的方法 |
RU2518247C2 (ru) * | 2011-07-26 | 2014-06-10 | Общество с ограниченной ответственностью "ГемаКор Лабс" (ООО "ГемаКор Лабс") | Способ определения пространственно-временного распределения активности протеолитического фермента в гетерогенной системе, устройство для реализации указанного способа и способ диагностики нарушений системы гемостаза по изменению пространственно-временного распределения активности протеолитического фермента в гетерогенной системе |
US11143659B2 (en) | 2015-01-27 | 2021-10-12 | Arterez, Inc. | Biomarkers of vascular disease |
RU2752776C1 (ru) * | 2020-12-16 | 2021-08-03 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Алтайский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ определения длительности тромбопрофилактики низкомолекулярным гепарином после абдоминального родоразрешения у носителей мутации Лейден, генотип F5 G1691A |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE464135B (sv) † | 1989-07-14 | 1991-03-11 | Kabivitrum Ab | Foerfarande foer bestaemning av funktionell aktivitet av fritt protein s eller protein c i ett plasmaprov |
WO1991001383A1 (en) * | 1989-07-14 | 1991-02-07 | Michigan State University | Method for diagnosing blood clotting disorders |
US5051357A (en) * | 1989-07-14 | 1991-09-24 | Board Of Trustees Operating Michigan State University | Method and assay using inactivation of factors Va and VIIIa by activated Protein C to diagnose thrombic disease or assay for Protein C and kit therefor |
US5169786A (en) * | 1989-12-19 | 1992-12-08 | Ortho Diagnostic Systems, Inc. | Method of determining levels of extrinsic and intrinsic clotting factors and protein c |
ES2154703T5 (es) † | 1994-11-10 | 2008-02-01 | Dade Behring Marburg Gmbh | Procedimiento para la deteccion especifica de un factor de coagulacion v activado con una estabilidad elevada frente a proteina c activada. |
US5705395A (en) † | 1994-11-14 | 1998-01-06 | The Scripps Research Institute | Method for diagnosis of thrombotic disorders |
-
1992
- 1992-05-13 DE DE69207607T patent/DE69207607T3/de not_active Expired - Lifetime
- 1992-05-13 DK DK92913443T patent/DK0608235T4/da active
- 1992-05-13 DE DE0608235T patent/DE608235T1/de active Pending
- 1992-05-13 WO PCT/SE1992/000310 patent/WO1993010261A1/en active IP Right Grant
- 1992-05-13 EP EP92913443A patent/EP0608235B2/de not_active Expired - Lifetime
- 1992-05-13 ES ES92913443T patent/ES2081618T5/es not_active Expired - Lifetime
- 1992-05-13 CA CA002119761A patent/CA2119761C/en not_active Expired - Lifetime
- 1992-05-13 AT AT92913443T patent/ATE132909T1/de not_active IP Right Cessation
- 1992-05-13 JP JP5509186A patent/JP2562000B2/ja not_active Expired - Lifetime
-
1996
- 1996-01-11 GR GR950403711T patent/GR3018646T3/el unknown
-
1997
- 1997-03-13 HK HK31697A patent/HK31697A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69207607T3 (de) | 2006-07-06 |
DK0608235T4 (da) | 2005-05-30 |
JP2562000B2 (ja) | 1996-12-11 |
CA2119761A1 (en) | 1993-05-27 |
DE608235T1 (de) | 1994-12-22 |
GR3018646T3 (en) | 1996-04-30 |
HK31697A (en) | 1997-03-21 |
WO1993010261A1 (en) | 1993-05-27 |
CA2119761C (en) | 1997-12-16 |
DE69207607T2 (de) | 1996-06-20 |
ES2081618T5 (es) | 2005-09-01 |
JPH07501217A (ja) | 1995-02-09 |
EP0608235B2 (de) | 2005-05-04 |
EP0608235A1 (de) | 1994-08-03 |
ES2081618T3 (es) | 1996-03-16 |
DK0608235T3 (da) | 1996-02-12 |
AU2198092A (en) | 1993-06-15 |
AU666484B2 (en) | 1996-02-15 |
EP0608235B1 (de) | 1996-01-10 |
DE69207607D1 (de) | 1996-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE132909T1 (de) | Vefahren zur diagnose von störungen der blutgerinnung | |
WO1997012992A3 (en) | Diagnosis method for a disease caused by a frameshift mutation in a gene and reagents therefore | |
CA2282746A1 (en) | Prediction of coronary artery disease | |
DK0868519T3 (da) | Diagnose og behandling af AUR-1- og/eller AUR-2-relaterede lidelser | |
DK0994963T3 (da) | Noninvasiv prænatal diagnose | |
EP0391714A3 (de) | Verfahren zum Nachweis der Alzheimer-Krankheit: Untersuchung des nicht-neuralen Gewebes | |
NO972006D0 (no) | Ny metode for diagnose av sykdommer | |
ATE63168T1 (de) | Kontroll- bzw. eichserum fuer die lipiddiagnostik. | |
WO1999037788A3 (en) | Diagnosis and treatment of aur1 and/or aur2 related disorders | |
ATE223051T1 (de) | Verfahren zur diagnose gutartiger prostataerkrankungen | |
DK0947585T3 (da) | Forbedret in vitro-fremgangsmåde, kits og reagenser til screening for blodkoagulationsdefekter | |
DE69002623D1 (de) | Verfahren zur abtrennung und reinigung von sialyl-transferasen. | |
DE69729954D1 (de) | Identifizierungsverfahren für Substanzen die an das Pyk2 Polypeptid binden | |
DE3783966D1 (de) | Reagens zur pruefung von periodentalen erkrankungen. | |
ATE272214T1 (de) | Verfahren zur diagnose von sepsis unter bestimmung von s100b | |
ATE189742T1 (de) | Test zur diagnose von demenz | |
WO2002033420A3 (en) | A urine test for the diagnosis of prion diseases | |
DE69734890D1 (de) | Rdgb-proteine | |
CA2332310A1 (en) | Antibody against protein tyrosine phosphatase intracellular domains | |
ES2099876T3 (es) | Procedimiento para la determinacion de anticuerpos de lupus anticoagulante que provocan trombosis. | |
RU2141667C1 (ru) | Способ диагностики эрозивного гастродуоденита и язвенной болезни у детей | |
SU1714510A1 (ru) | Способ определени гормональной зависимости при аутоиммунных заболевани х | |
DE69918128D1 (de) | Mutierte gewebefaktor-inhibitor (tfpi), dna sequenz davon und verwendung zur erkennung von thrombotischen erkrankungen | |
WO1999064584A3 (de) | Protein zur regulation von apoptose | |
RU93013396A (ru) | Способ определения мембранной активации свертывания плазмы крови |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |